Dr. Ricardo J. Gonzalez, MD

Dr. Gonzalez practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Gonzalez's NPI, 1275632929, was assigned on September 21, 2006. Dr. Gonzalez graduated from USF Health Morsani College of Medicine in 1997. Dr. Gonzalez holds Florida license ME102674.

Dr. Gonzalez's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Gonzalez also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Dr. Gonzalez's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Gonzalez to 1 more breast imaging center and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gonzalez practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Gonzalez's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Gonzalez is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Gonzalez's licenses on file in 3 states: Florida, Colorado and Texas.

Dmand AI lists cancerous skin growth removal, colon removal, esophagus, stomach, or upper small intestine surgery and removal of damaged skin or skin graft among the conditions Dr. Gonzalez treats.

CMS data shows 245 Medicare services from Dr. Gonzalez across 9 procedure codes in 2024, for 184 Medicare patients. Medicare paid $26,097 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 184 Medicare patients who saw Dr. Gonzalez in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gonzalez's median patient age at 68, with 44% women.

In 2024, Dr. Gonzalez wrote 22 Medicare Part D claims for 16 patients. 95% of them were for generic drugs. They cover 2 drugs, with $96 in total drug cost. In 2020, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Gonzalez for performance year 2024, reported as part of a group. Dr. Gonzalez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of melanoma (skin cancer) excision by Dr. Gonzalez, more than 69% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 97 papers to Dr. Gonzalez, published from 2007 to 2025. 2015 was the busiest year, with 6. The most frequent topics are Sarcoma, Neutrophils and Skin Neoplasms. Dr. Gonzalez has published most often in Ann Surg Oncol. Dr. Gonzalez's most frequent co-authors are Jonathan S. Zager, MD, Vernon K. Sondak, MD and Marilyn Yuanxin Ma Bui, MD.

CMS Open Payments shows 83 general payments to Dr. Gonzalez from 14 drug and device companies from 2016 to 2024. Education speaker fees make up the largest share, 32% of the total. Novartis Pharmaceuticals Corporation paid the most, $7,627. It also lists 1 research payment totaling $1,316 in 2017.

Dmand AI lists 1 award for Dr. Gonzalez.

Dr. Gonzalez graduated from USF Health Morsani College of Medicine in 1997. Dr. Gonzalez is a member of ACS.

Dr. Gonzalez is in network with 8 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.